Stocktoria
Nano-X Imaging Ltd. NNOX
Nano-X Imaging Ltd. (NNOX) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $13.0M at a -576.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.308 |
| Retained earnings / assets | -2.767 |
| EBIT / assets | -0.482 |
| Equity / liabilities | 6.229 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | 2/9 | -3.7 | — | +15.4% |
| BFLY | Butterfly Network, Inc. | 3/9 | -5.51 | — | +19% |
| GEHC | GE HealthCare Technologies Inc. | 4/9 | 1.99 | 14.4 | +4.8% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
| HMC | HONDA MOTOR CO LTD | 6/9 | 2.79 | — | +19.9% |
| SONY | Sony Group Corp | 6/9 | 0.86 | — | +9% |
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligencebased solution; AI-Based Body Composition Measurement, an artificial intelligencebased body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
FAQ
Is NNOX financially healthy?
Nano-X Imaging Ltd.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does NNOX pay a dividend?
No, Nano-X Imaging Ltd. does not currently pay a dividend.
How profitable is NNOX?
In FY2025, Nano-X Imaging Ltd. had a net margin of -576.1% and a return on equity of -53.7%.
What is the analyst price target for NNOX?
The average Wall-Street price target for Nano-X Imaging Ltd. is $6.53, about 540.5% above the recent price, from 3 analysts (consensus: strong buy).
Is NNOX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Nano-X Imaging Ltd.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.